-

Allscripts Sunrise™ Wins Best in KLAS Award

Acute solution named 2020 Best in KLAS - Global Acute Care EMR (Canada)

RICHMOND, British Columbia--(BUSINESS WIRE)--KLAS Research named Allscripts (NASDAQ: MDRX) Sunrise™ as 2020 Best in KLAS - Global Acute Care EMR (Canada). Allscripts Sunrise Acute Care is a clinical solution that provides advanced decision support, such as Computerized Physician Order Entry (CPOE), to help hospital teams improve patient care. According to the 2020 Best in KLAS - Global Acute Care EMR (Canada) report, the solution outpaced competitors in delivering new technology and earning customer loyalty.

“Providers and payers demand better performance, usability, and interoperability from their vendor partners every year,” says Adam Gale, President of KLAS. “Best in KLAS winners set the standard of excellence in their market segment. Earning a Best in KLAS award should both excite and humble the recipients. It serves as a signal to providers that they can expect the best from the winning vendors.”

KLAS Research independently monitors healthcare technology performance through the active participation of users. Healthcare professionals evaluate the software they use, and KLAS Research analyzes and publishes the results in its annual Best in KLAS: Global Software (Non-US) report.

"This Best in KLAS award demonstrates Allscripts Sunrise comprehensive and flexible features that our clients require when facing today’s challenges in delivering complex care models,” said President of Allscripts Global, Alan Fowles. “Allscripts continues to focus on delivering industry leading, highly coordinated service to our clients globally and is proud that Sunrise is helping hospitals and health systems around the globe improve the clinician experience and provide quality patient care.”

Used by healthcare organizations across the globe, Allscripts Sunrise is an integrated electronic patient record that connects all aspects of care, including acute, ambulatory, surgical, radiology and personalized medicine. Built to enable efficient and safe care, Sunrise is a clinician-friendly, evidence-based single platform with advanced analytics that helps deliver true personalized medicine. Sunrise supports all core care venues across the enterprise by delivering a single patient record, and features patient-centric capabilities that can increase access and convenience for the consumer.

Allscripts celebrates this award with our Canadian clients who continue to deliver exceptional care every day.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

About KLAS

KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment and infrastructure systems to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving supplier performance. KLAS was founded in 1996, and their staff and advisory board average 25 years of healthcare information technology experience. Follow KLAS on Twitter at www.twitter.com/KLASresearch.

© 2020 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Contacts

For more information contact:
Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

Allscripts

NASDAQ:MDRX

Release Versions
Hashtags

Contacts

For more information contact:
Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

More News From Allscripts

Veradigm Launches Enhanced Ambient Scribe Capabilities

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced enhancements to the artificial intelligence (AI) enhanced Ambient Scribe solution for Veradigm EHR customers. This milestone reflects Veradigm’s commitment to delivering evolved AI solutions that improve clinical documentation, support clinical decision-making, and enhance patient care. Since its launch last year, Veradigm Ambient Scribe has developed into a robus...

Veradigm Adds Sentara Health Plans to Veradigm Payer Insights Solution

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today a new agreement with Sentara Health Plans, a prominent regional health plan, serving more than one million members. Sentara will implement the Veradigm Payer Insights software solution to deliver patient-specific care gap alerts within the electronic health record (EHR) systems used by its network providers. Veradigm Payer Insights displays critical care gap alert...

Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today appoints Tehsin Syed, a healthcare technology leader with over two decades of experience, as Chief Product and Technology Officer. Syed most recently served as General Manager, AWS Health AI (Amazon Web Services). Under his leadership, the organization scaled as a growth engine, with net-new products for ambient clinical documentation, genomics, and medical imaging, and int...
Back to Newsroom